Your trusted source for investing success

Tag: biomedical

Get Our Expert Guide to Lithium Investing - FREE!

Click here to download your FREE INN Report on the lithium market, "Lithium Forecast & Lithium Stocks To Buy".    
Gain Access
Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder.

 “The goal of our collaboration with Sphaera Pharma is to put the patient first, especially since QBM-001 targets a rare subset of toddlers

Q BioMed Inc Closes $3,050,390 Equity Financing

Q BioMed Inc Closes $3,050,390 Equity Financing

Q BioMed Inc. (OTCQB:QBIO), is pleased to announce the closing of a $3,050,390 equity financing. The financing with a small group of accredited investors provides the necessary capital to meet near term milestones and catalysts in its most advanced product portfolio assets, including the commercialization of Strontium Chloride 89, multiple IND

Q BioMed Inc : SeeThruEquity Issues Update on Q BioMed Inc. (QBIO)

Q BioMed Inc : SeeThruEquity Issues Update on Q BioMed Inc. (QBIO)

SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Q BioMed Inc. (OTCQB:QBIO).

Q BioMed Inc. (OTCQB: QBIO) is a biomedical acceleration and development company focused on identifying, acquiring and licensing attractive biomedical assets from small

Q Biomed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team

Q Biomed Inc. Adds Nuclear Medicine Industry Veteran to Commercialization Team

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today that Christopher Manuele will join the Strontium 89 Chloride commercialization team.
Mr. Manuele is a results-oriented, innovative executive with thirty-five years of comprehensive US and International expertise in nuclear medicine and medical isotope production. A long-time veteran of Amersham Health and

Friday Night Signs Licensing Agreement with Gilla

Friday Night Signs Licensing Agreement with Gilla

Friday Night Inc. (the “Company”) (CSE:TGIF) (FRANKFURT:1QF) has entered into a production and distribution licensing agreement (the “Licensing Agreement”) with Gilla Enterprises Inc. (“Gilla”), a wholly-owned subsidiary of Gilla Inc. (OTCQB:GLLA), to introduce and launch Gilla’s new portfolio of cannabis concentrate products in the State of Nevada. The Licensing Agreement

Q Biomed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation And The Rajiv Gandhi Centre For Biotechnology For Novel Liver Cancer Treatment

Q Biomed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation And The Rajiv Gandhi Centre For Biotechnology For Novel Liver Cancer Treatment

Q BioMed Inc. (OTCQB:QBIO), is very pleased to announce their entry into a final license agreement with The Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB). Under the agreement QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat

Friday Night Inc, formerly QuikFlo Health Inc. announces name change, share consolidation, closing of acquisition of Las Vegas medical marijuana interests, private placement closing and management changes

Friday Night Inc, formerly QuikFlo Health Inc. announces name change, share consolidation, closing of acquisition of Las Vegas medical marijuana interests, private placement closing and management changes

Friday Night Inc, formerly QuikFlo Health Inc. (the “Company”) (CSE:TGIF) (FRANKFURT:1QF) announces that in conjunction with the closing of its previously announced acquisition of interests in two cannabis based businesses located in Las Vegas, Nevada, it has changed its name to Friday Night Inc. and consolidated its shares on a

PyroGenesis Announces Creation of “PyroGenesis Additive”

PyroGenesis Canada (TSXV:PYR) has announced that it has created a new division under the name of “PyroGenesis Additive,” dedicated primarily to PyroGenesis’ additive manufacturing line.

As quoted in the press release:
PyroGenesis is the inventor of Plasma Atomization, using this process to produce very small, uniform, fully dense and spherical metal powders

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
How to Participate in the Lithium Boom

URL: https://investingnews.com/daily/resource-investing/energy-investing/lithium-investing/participate-lithium-boom/